Proposed
Bill · 119th Congress · S 4327
Securing America’s Drug Supply from Communist China Act
Refreshed 3 h ago
Introduced 2026-04-16Topic: health care · public healthSummary
AI-generated summary, report an errorThis bill would require the Food and Drug Administration to review drug applications from Chinese companies, or companies licensing products owned by Chinese companies, to determine whether the sponsor is supported by or affiliated with the Chinese government, the Chinese Communist Party, or the People's Liberation Army. New applications from affiliated sponsors could not be approved. The agency would also review applications submitted from January 1, 2016, until the bill becomes law. Imported drugs whose sponsor or application holder is found to be affiliated would be refused and destroyed by Customs and Border Protection, unless the company shows it is no longer affiliated, sells the application within 180 days, or a waiver is granted to avoid a drug shortage. The bill authorizes $5,000,000 to carry out these steps.
Sponsors
- Tom Cotton Republican sponsor
- 1 cosponsors
Action history
| Date | Chamber | Action | Status effect |
|---|---|---|---|
| 2026-04-16 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. | refer |
| 2026-04-16 | Introduced in Senate | introduce |